enter here
Ketamine Versus Electroconvulsive Therapy in Depression
About the study
NCT Trial Number
NCT03674671
The drug being studied
Ketamine
Sponsored by
University of Ottawa|McGill University|Queen's University|Sunnybrook Health Sciences Centre|University Health Network, Toronto
Trial Start Date
Oct-18
About the participants
Age seeking
18 Years to 70 Years
gender
All
Primary condition of volunteers accepted
Depression
Accepts healthy volunteers?
This study aims to compare treatment outcomes from a course of IV ketamine compared to ECT in patients with depression.
Locations
Canada, Ontario
Providence Care Hospital
Kingston, Ontario, Canada, K7M 9A7
Contact: Emily Hawken, PhD
hawken@queensu.ca
Royal Ottawa Mental Health Centre
Ottawa, Ontario, Canada, K1Z 7K4
ubah.mohamed@theroyal.ca
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Contact: Anusha Baskaran, PhD
416-480-6100 ext 1650
anusha.baskaran@sunnybrook.ca
Contact: Sachie Sharma
416-480-6100 ext 3254
sachie.sharma@sunnybrook.ca
University Health Network
Toronto, Ontario, Canada, M5G 1J6
Contact: Franca Placenza, PhD
416-603-5800 ext 8839
franca.placenza@uhn.ca
Douglas Mental Health University Institute
Verdun, Ontario, Canada, H4H 1R3
Get in contact
Find a study site convenient for you below, then email yourself the contact details and next steps